Raffaele Ferria, b, Lilia Curzi-Dascalovad, Stefano Del Graccob, Maurizio Ellab, Salvatore Pettinatoc, Sebastiano A. Musumecib
a Sleep Research Center, b Department of Neurology, c Department of Neurophysics, Oasi Institute for Research on Mental Retardation and Brain Aging, Via Conte Ruggero 73, 94018 Troina Italy. (Tel: +39-935-936111, Fax: +39-935-653327), d INSERM, Laboratoire de Physiologie-EF, Hôpital Robert Debré, Paris.
Reprinted with the permission of the principal author, Raffaele Ferri|
Paper presented at the 6th World Congress on Down Syndrome
In this paper, research on sleep characteristics of subjects with Down syndrome is briefly reviewed and some new data on autonomic function during sleep are reported. Subjects with Down syndrome show a significant reduction in percentage of REM sleep (probably more evident in the most severely retarded subjects), a marked delay in first REM latency and a statistically significant decrease in high-frequency rapid eye movements during REM sleep. The percentage of REM sleep in humans can be considered as an index of brain "plasticity" and the high-frequency REMs can represent an index of the brain ability to organize information; thus, these studies have provided a neurophysiological basis to a psychopedagogical approach for the treatment of learning and memory disabilities in Down syndrome. Moreover, children with Down syndrome show a clearly decreased peak amplitude of growth hormone during sleep; this causes the poor physical development in these subjects and might be related to the occurrence of sleep apnea. Obstructive sleep apnea has also been repeatedly reported in these children; however, if obvious risk factors are absent, children with Down syndrome tend to show the presence of central sleep apnea which is caused by a probable dysfunction of autonomic control at a brainstem level.
Sleep and Mental Retardation
According to Jackson's sleep-cognition hypothesis (1932), which postulates that cognitive deficits might be associated with alterations in sleep mechanisms and structure, several studies were carried out on sleep patterns of subjects with mental retardation of different etiologies (Petre-Quadens & Jouvet, 1966; Petre-Quadens, 1969; Castaldo & Krynicki, 1973, 1974; Grubar, 1983). The main findings of such studies were a reduction in percentage of rapid eye movement (REM) sleep and a prolonged latency of the first REM period in individuals with a mental handicap. Based also on the observation that, in animals, REM sleep percentage increases after intensive learning sessions (McGrath & Cohen 1978; Mirmiran, van den Dungen, & Uylings, 1982) the hypothesis that REM sleep is involved in cognitive processes was postulated and REM sleep itself was indicated as an index of brain "plasticity" - i.e. the ability of the brain to retain information.
When REMs were considered, it was observed that patients with mental retardation also show a significant reduction in REMs separated by short time intervals (< 1 sec) (Grubar, 1983). High-frequency REMs show a marked increase with age (Petre-Quadens, 1980) and increase after training (Spreux, Lambert, Chevalier, Meriaux, Freixa et al., 1982). For these reasons, they were considered as an index of the brain "organizational" abilities - i.e. the ability to organize information from a random pool of elements into long-term memory.
Sleep and Down syndrome
Similarly to other groups of individuals with mental retardation, patients with Down syndrome show a significant reduction in the percentage of REM sleep (probably more evident in the most severely retarded subjects), a marked delay in first REM latency and a statistically significant decrease in high-frequency REMs during REM sleep (Colognola et al., 1988). In order to study the mechanisms of such a reduction in REM percentage, the effects of the administration of a drug, butoctamide hydrogen succinate (BAHS) an organic compound found in cerebrospinal fluid of normal subjects (Yanagisawa & Yoshikawa, 1973), on the sleep patterns of subjects with Down syndrome were repeatedly evaluated in different experimental protocols (Gigli, Bergonzi, Grubar, Colognola, Amata, et al., 1985; Gigli, Grubar, Colognola, Amata, Pollicina, et al., 1987; Grubar, Gigli, Colognola, Ferri, Musumeci, et al., 1985; Grubar, Gigli, Colognola, Ferri, Musumeci, et al., 1986). BAHS was able to increase the amount REM sleep in subjects with Down syndrome, similar to its effects in normal controls and in animals; however, high-frequency REMs were unaffected by the administration of this substance. On the other hand, intensive learning sessions were able to increase the ratio between high-frequency and low-frequency REMs but did not affect REM percentage (Gigli et al., 1985; Gigli et al., 1987).
These results supported the basic hypothesis that the percentage of REM sleep in humans can be considered as an index of brain "plasticity" (reduced in the elderly and in children with mental retardation) and that the high-frequency REMs can represent an index of the brain ability to organize information (also involved in individuals with mental retardation) (Gigli et al., 1987). At the same time, such studies gave a neurophysiological basis to a psychopedagogical approach for the treatment of learning and memory disabilities in Down syndrome.
Down syndrome and growth hormone production during sleep
It is well known that, in normal subjects, growth hormone (GH) is released during sleep in a pulsatile pattern with peaks during slow-wave sleep (SWS) (Takahashi, Kipnis, & Daughaday, 1968; Van Cauter et al., 1992) and this mechanism seems to be mediated by hypothalamic neurons located around the ventral-medial nucleus projecting to the preoptic region (Sawchenco, Swanson, Rivier, & Vale, 1985).
The mean height of adults with Down syndrome is below 3 standard deviations of the mean for normal subjects, both in males and females (Penrose & Smith, 1966) and a dysfunction of GH production during sleep is strongly suspected in Down syndrome (Castells, Torrado, Bastian, & Wisniewski, 1992). Given the above sleep alterations, the relationships between sleep structure and GH production in a group of children with Down syndrome were studied (Ferri et al., 1996) and it was demonstrated that they show a clearly decreased peak amplitude of GH; however, a certain pulsatility was evident in all patients but synchrony with SWS was poor. Thus, it can be concluded that, if evaluated during sleep, GH release in Down syndrome often shows abnormalities.
Additionally, it should be considered that many subjects with Down syndrome have been reported to present obstructive sleep apnea (Marcus, Keens, Bautista, von Pechmann, & Davidson Ward, 1991) and that GH release is known to be reduced in children with this sleep disorder, probably because of the consequent sleep fragmentation, and it becomes normal if an effective treatment of apnea is started (Grunstein, Stewart, & Sullivan, 1992; Matsumoto, Sandblom, Schoene, Lee, Giblin, et al., 1985). Moreover, children with sleep apnea show short stature which can be corrected by treatment of the apnea (Broulliette, Fernbach, & Hunt, 1982; Goldstein, Wu, Thorpy, Shprintzen, Marion, et al., 1987).
Sleep apnea in Down syndrome
There have been many reports of obstructive sleep apnea (OSA) episodes occurring in patients with Down syndrome; in particular, Southall et al. (1987) found, in their group of 12 infants and young children with Down syndrome, that 50% of them were affected by OSAs. Marcus et al. (1991) reported that all of their overnight polysomnographic studies, performed in 16 patients with Down syndrome, were abnormal for the presence of OSAs in 63%, hypoventilation in 81%, and oxygen desaturation in 56%; Stebbens et al. (1991) reported OSAs in 10 of their 32 subjects with Down syndrome.
However, there were no data on respiratory patterns of subjects with Down syndrome without obvious risk factors for OSA; thus, in order to evaluate the eventual effects of CNS impairment on respiration in Down syndrome, the respiratory patterns during sleep of a group of 10 subjects with Down syndrome, aged 8.6-32.2 years, without relevant upper airway pathology were studied (Ferri, Curzi-Dascalova, Del Gracco, Elia, Musumeci, et al., 1997). The possible effects of sleep pattern and mental retardation on the results obtained were controlled by comparing data from Down syndrome with those obtained from a group formed by subjects with fragile X syndrome (6 males and 1 female, aged 10.0-15.42 years), another genetically determined type of mental retardation. Sleep structure was similar in both groups; however, subjects with Down syndrome showed significantly higher values of central sleep apnea and of oxygen desaturation than fragile X patients.
In patients with Down syndrome a significant preponderance of central, as opposed to obstructive, sleep apneas was found which also showed a significant age-related increase. Central apneas were mostly preceded by sighs, occurred more frequently during sleep stages 1 and REM, and were often organized in long sequences of periodic breathing. Sleep structure was not significantly modified by apneas and oxygen desaturation. In this study, it was hypothesized that the increase in central sleep apneas is related to a dysfunction of central respiratory control at the brainstem level in Down syndrome (Ferri et al., 1997).
The brainstem is suspected to be the probable site of dysfunction because a deficit in brainstem inhibitory mechanisms has already been suggested in Down syndrome, as an explanation for the shortening of the central conduction time of brainstem auditory evoked potentials, usually observed in these subjects (Gigli et al., 1984). In addition, this peculiar feature becomes more evident with age in patients with Down syndrome (Ferri, Del Gracco, Elia, Musumeci, & Stefanini, 1995).
Moreover, taking into account the sleep structure alterations usually seen in Down syndrome, as seen above, because of the absence of correlation between apnea indices and REM sleep features in the above results, sleep apnea does not seem to be responsible for the decrease in REM sleep percentage and the increase in REM latency in such a group of patients with Down syndrome.
Heart rate variability during sleep in Down syndrome
In order to confirm a brainstem dysfunction causing central sleep apnea, heart rate variability during sleep in a group of 7 patients with Down syndrome (mean age 13.9 years) was evaluated and compared with the results obtained in a group of 6 normal controls (mean age 12.8 years). Heart rate is under control of efferent sympathetic and vagal activities directed to the sinus node which is modulated by central brainstem (vasomotor and respiratory centers) and peripheral (oscillation in arterial pressure and respiratory movements) oscillators (Malliani, Pagani, Lombardi, & Cerutti, 1991). Spectral analysis of heart rate variability is a quantitative reliable method for analyzing the modulatory effects of neural mechanisms on the sinus node (Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology, 1996) and two main components are currently considered: vagal activity which is the major contributor to the high-frequency component while the low-frequency component is considered by some authors to be a marker of sympathetic modulation and by others as a parameter including both vagal and sympathetic influences.
The spectral analysis of heart rate variability during the different stages of sleep and during epochs with or without episodes of central sleep apnea was also performed (Ferri, Curzi-Dascalova, Del Gracco, Elia, Musumeci, et al., submitted). The comparison between patients with Down syndrome and normal controls carried out only on epochs without apnea showed a significant alteration of the ratio between the low-frequency and high-frequency components in Down syndrome in all sleep stages, with a statistical significance for sleep stage 1 and slow-wave sleep (Figure 1). The sympathetic-correlated low-frequency component was always higher in Down syndrome; on the other hand, the vagal-controlled high-frequency component was always lower in the same group. Also in this study, a low frequency of obstructive sleep apnea was found because subjects were selected with the same criteria of the previous investigation on central sleep apnea (Ferri et al., 1997). The presence of this type of apnea, in patients with Down syndrome, induced a further significant increase in low-frequency and very-low-frequency components of heart rate variability, similarly to the effects of the presence of OSA already described in the literature (Schiomi, Guilleminault, Sasanabe, Hirota, Maekawa, et al., 1996).
Figure 1. Ratio between the low-frequency and the high-frequency components of the spectrum of heart rate variability during sleep in patients with DS and normal controls.
W = wakefulness, S1 = sleep stage 1
S2 = sleep stage 2, SWS = slow-wave sleep
REM = rapid eye movement sleep
This final study is additional evidence for impaired brainstem function in Down syndrome which is demonstrated by abnormalities in brainstem auditory evoked potentials, abnormal presence of central sleep apnea and impaired balance between sympathetic and vagal control of heart rate variability during sleep.
Finally, the altered balance between the sympathetic and vagal systems can be viewed also in psychophysiological terms, following the ideas of the so-called "Polyvagal Theory" (Forges, 1995) which states that the vagal system does not represent a unitary dimension and is formed by two distinct motor systems. The first one is the "vegetative status" originating in the dorsal motor nucleus, associated with passive automatic regulation of visceral subdiaphragmatic functions, the second is the "smart vagus", originating in the nucleus ambiguus (NA), associated with the active processes of attention, motion, emotion, and communication, with supradiaphragmatic target organs. Thus, the changes reported in the autonomic function of subjects with Down syndrome, together with the already reported changes in central control of respiration (Ferri et al., 1997), might be physiopathologically connected with the basic mechanisms of their developmental psychomotor problems. In this respect, there is a need of further research.
Broulliette, R.T., Fernbach, S.K., & Hunt, C.E. (1982). Obstructive sleep apnea in infants and children. Journal of Pediatrics, 100, 31-40.
Castaldo, V, & Rrynicki, V (1973). Sleep patterns and intelligence in functional mental retardation. Journal of Mental Deficiency Research, 74, 231-235.
Castaldo, V, & Krynicki, V. (1974). Sleep and eye movement patterns in two groups of retardates. Biological Psychiatry, 6, 295-299.
Castells, S., Torrado, C., Bastian, W, & Wisniewski, K.E. (1992). Growth hormone deficiency in Down's syndrome children. Journal of Intellectual Disability Research, 36, 29-43.
Colognola, R.M., Musumeci, S.A., Ferri, R., Grubar, J.C., Bergonzi, R, & Gigli, G.L. (1988). REM sleep and mental retardation (MR): Comparison among three groups with homoneous karyotype. In W.P. Koella, F. Obl, H. Schulz H, P. Visser (Eds.) Sleep '86, pp. 370-372. Stuttgart: Gustav Fisher Verlag.
Ferri, R., Curzi-Dascalova, L., Del Gracco, S., Elia, M., Musumeci, S.A., & Pettinato, S. (1998). Heart rate variability and apnea during sleep in Down's syndrome, submitted.
Ferri, R., Curzi-Dascalova, L., Del Gracco, S., Elia, M., Musumeci, S.A., & Stefanini, M.C. (1997). Respiratory patterns during sleep in Down's syndrome: importance of central apnoeas. Journal of Sleep Research, 6, 134-141.
Ferri, R., Del Gracco, S., Elia, M., Musumeci, S.A. & Stefanini, M.C. (1995). Age, sex and mental retardation related changes of brainstem auditory evoked potentials in Down's syndrome. Italian Journal of Neurological Sciences, 16, 377-383.
Ferri, R., Ragusa, E., Alberti, A., Elia, M., Musumeci, S.A., Del Gracco, S., Romano, C., & Stefanini, M.C. (1996). Growth hormone and sleep in Down syndrome. Developmental Brain Dysfunction, 9, 114-120.
Gigli, G.L., Bergonzi, P., Grubar, J.C., Colognola, R.M., Amata, M.T., Pollicina, C., Musumeci, S.A., & Ferri, R. (1985). Effects of intensive learning sessions on nocturnal sleep in Down's syndrome (DS) children. Comparison with the effects of an experimental drug (BAHS). In W.P. Koella, E. Rather, H. Schulz (Eds.) Sleep '84, pp. 361-363. Stuttgart: Gustav Fisher Verlag.
Gigli, G.E., Ferri, R., Musumeci, S.A., Tomassetti, P., & Bergonzi, P. (1984). Brainstem auditory evoked responses in children with Down's syndrome. In J.M. Berg (Ed.) Perspectives and Progress in Mental Retardation. Vol 11. Biomedical Aspects, pp. 277-286. Baltimore: University Park Press.
Gigli, G.L., Grubar, J.C., Colognola, R.M., Amata, M.T., Pollicina, C., Ferri, R., Musumeci, S.A., & Bergonzi, R (1987). Butoctamide hydrogen succinate and intensive learning sessions: effects on night sleep of Down's syndrome patients. Sleep, 10, 563-569.
Goldstein, S.J., Wu, R.H.K., Thorpy, M.J., Shprintzen, R.J., Marion, R.E., & Saenger, P. (1987). Reversibility of deficient sleep entrained growth hormone secretion in a boy with achondroplasia and obstructive sleep apnea. Acta Endocrinologica (Copenh.), 116, 95-101.
Grubar, J.C., Gigli, G.E., Colognola, R.M., Ferri, R., Musumeci, S.A., & Bergonzi, P. (1985). Effects of butoctamide (BAHS) on nocturnal sleep of Down's syndrome children. Comparison with the effects of an experimental drug. In WR Koella, E. R ther, H. Schulz (Eds.) Sleep '84, pp. 420-422. Stuttgart: Gustav Fisher Verlag.
Grubar, J.C., Gigli, G.L., Colognola, R.M., Ferri, R., Musumeci, S.A., & Bergonzi, R (1986). Sleep patterns of Down's syndrome children: effects of (BAHS) administration. Psychopharmachology, 90, 119-122.
Grubar, J.C. (1983). Sleep & Mental deficiency. Revue EEG Neurophysiologie Clinique, 3, 107-114.
Grunstein, R., Stewart, D., & Sullivan, C. (1992). Endocrine and metabolic disturbances in obstructive sleep apnea. In S. Smirne, M. Franceschi, L. Ferini-Strambi, & M. Zucconi (Eds.) Sleep, Hormones and Immunological System, pp. 111-122. Milano: Masson.
Jackson, J. (1932). Selected Writings of John Hughlings Jackson. J. Taylor (Ed.). London: Hayden and Stoughton.
Malliani, A., Pagani, M., Lombardi, R, & Cerutti, S. (1991). Cardiovascular neural regulation explored in the frequency domain. Circulation, 84, 1482-1492.
Marcus, C.L., Keens, T.G., Bautista, D.B., von Pechmann, W.S., & Davidson Ward, S.L. (1991). Obstructive sleep apnea in children with Down syndrome. Pediatrics, 88, 132-139.
Matsumoto, A.M., Sandblom, R.E., Schoene, R.B., Lee, K.A., Giblin, E.G., Pierson, D.J., & Bremner, W.J. (1985). Testosterone replacement in hypogonadal males: Effects on obstructive sleep apnea, respiratory drives and sleep. Clinical Endocrinology, 22, 713-721.
McGrath, M.J., & Cohen, D.B. (1978). REM sleep facilitation of adaptive waking behavior: A review of the literature. Psychology Bulletin, 85, 24-57.
Mirmiran, M., van den Dungen, H., & Uylings, H. (1982). Sleep patterns during rearing under different environmental conditions in juvenile rats. Brain Research, 233, 287-298.
Penrose, L.S., & Smith, G.F. (1966). Down's Anomaly. London: Churchill.
Petre-Quadens, O. (1969). Contribution a 1'etude de la phase dite paradoxale du sommeil. Ada Neurologica Psychiatrica Belgica, 69, 769-898.
Petre-Quadens O. (1980). Physiologic du sommeil et environment. Totus Homo, 12, 14-22.
Petre-Quadens O., & Jouvet, M. (1966). Paradoxical sleep in mental retardation. Journal of Neurological Sciences, 3,608-612.
Forges, S.W. (1995). Orienting in a defensive world: Mammalian modifications of our evolutionary heritage. A polyvagal theory. Psychophysiology, 32, 301-318.
Sawchenco, RE., Swanson, L.W, Rivier, J., & Vale, W.W. (1985). The distribution of growth-hormone-releasing factor (GRF) immunoreactivity in the central nervous system of the rat: An immunohistochemical study using antisera directed against rat hypothalamic GRF. Journal of Comparative Neurology, 237, 100-115.
Schiomi, T, Guilleminault, C., Sasanabe, R., Hirota, I., Maekawa, M., & Kobayashi, T. (1996). Augmented very low frequency component of heart rate variability during obstructive sleep apnea. Sleep, 19, 370-377.
Southall, D.P, Stebbens, V.A., Mirza, R., Lang, M.H., Croft, C.B., & Shinebourne, E.A. (1987). Upper airway obstruction with hypoxaemia and sleep disruption in Down syndrome. Developmental Medicine and Child Neurology, 29, 734-742.
Spreux, F., Lambert, C., Chevalier, B., Meriaux, H., Freixa i Baque, E., Grubar, J.C., Lancry, A., & Leconte, P. (1982). Modifications des caracteristiques du sommeil paradoxale consecutifs a un apprentissage chez I'homme. Cahiers de Psychologic Cognitive, 2, 327-334.
Stebbens, VA., Dennis, J., Samuels, M.R, Croft, C.B., & Southall, D.P. (1991). Sleep related upper airway obstruction in a cohort with Down's syndrome. Archives of Disease Childhood, 6, 1333-1338.
Takahashi, Y, Kipnis, D.M., & Daughaday, W.H. (1968). Growth hormone secretion during sleep. Journal of Clinical Investigations, 47, 2079-2090.
Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. (1996). Heart rate variability. Standards of measurements, physiological interpretation and clinical use. Circulation, 93, 1043-1065.
Van Cauter, E., Kerkhofs, M., Caufriez, A., Van Ondergergen, A., Thorner, M.O., & Copinschi, G. (1992). A quantitative estimation of growth hormone secretion in man: Reproducibility and relation to sleep and time of day. Journal of Clinical Endocrinology and Metabolism, 74, 1441-1450.
Yanagisawa, I., & Yoshikawa, H. (1973). A bromine compound isolated from human cerebrospinal fluid and synthesis-related compounds. Biochemical Biophysical Acta, 329, 283-294.